Clough Capital Partners’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDOC
AIM
NAMA
KA
CS
Clough Capital Partners's TDOC Position: Q1 2022 in Review
Clough Capital Partners sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 94,050 shares — an estimated $8.64M sold.
Clough Capital Partners first reported a position in TDOC in Q1 2018 and held it in 15 quarters. The position peaked at $18.7M in Q3 2020. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.
- Clough Capital Partners reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
- Clough Capital Partners sold 94,050 Teladoc Health shares in Q1 2022, an estimated $8.64M.
- Clough Capital Partners first reported a position in Teladoc Health in Q1 2018 and held it in 15 quarters.
- Clough Capital Partners's Teladoc Health position peaked at $18.7M in Q3 2020.
- 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.
Based on Clough Capital Partners's 13F filing for Q1 2022, filed 16 May 2022.